JP2017525675A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525675A5
JP2017525675A5 JP2017500883A JP2017500883A JP2017525675A5 JP 2017525675 A5 JP2017525675 A5 JP 2017525675A5 JP 2017500883 A JP2017500883 A JP 2017500883A JP 2017500883 A JP2017500883 A JP 2017500883A JP 2017525675 A5 JP2017525675 A5 JP 2017525675A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
rotator cuff
tendon
polypeptide
bmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017500883A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017525675A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/039743 external-priority patent/WO2016007742A1/en
Publication of JP2017525675A publication Critical patent/JP2017525675A/ja
Publication of JP2017525675A5 publication Critical patent/JP2017525675A5/ja
Pending legal-status Critical Current

Links

JP2017500883A 2014-07-09 2015-07-09 回旋筋腱板異常の処置 Pending JP2017525675A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022516P 2014-07-09 2014-07-09
US62/022,516 2014-07-09
PCT/US2015/039743 WO2016007742A1 (en) 2014-07-09 2015-07-09 Treating rotator cuff conditions

Publications (2)

Publication Number Publication Date
JP2017525675A JP2017525675A (ja) 2017-09-07
JP2017525675A5 true JP2017525675A5 (enExample) 2018-07-19

Family

ID=55064896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500883A Pending JP2017525675A (ja) 2014-07-09 2015-07-09 回旋筋腱板異常の処置

Country Status (4)

Country Link
US (2) US10610570B2 (enExample)
EP (1) EP3166624B1 (enExample)
JP (1) JP2017525675A (enExample)
WO (1) WO2016007742A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017011762A1 (en) 2015-07-16 2017-01-19 Mayo Foundation For Medical Education And Research Treating rotator cuff conditions
JP2023501925A (ja) * 2019-10-24 2023-01-20 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ 筋線維断片を利用した回旋腱板療法
US12310928B2 (en) 2020-11-16 2025-05-27 University Of Utah Research Foundation Enthesis healing
WO2024015257A1 (en) * 2022-07-15 2024-01-18 Mayo Foundation For Medical Education And Research Methods and materials for promoting bone growth

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US5939388A (en) * 1986-07-01 1999-08-17 Rosen; Vicki A. Methods of administering BMP-5 compositions
SG46445A1 (en) 1990-01-26 1998-02-20 Immunomedics Inc Vaccines against cancer and infectious diseases
DE69629294T2 (de) * 1995-06-05 2004-04-29 Genetics Institute, LLC, Cambridge Verwendung von knochenmorphogeneseproteinen zur heilung und reparatur von bindegewebebefestigung
CA2463143A1 (en) * 2001-10-31 2003-07-10 Alcon, Inc. Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
US20040191338A1 (en) * 2002-12-18 2004-09-30 Algorx Administration of capsaicinoids
NZ547140A (en) 2003-10-22 2009-09-25 Encelle Inc Bioactive hydrogel compositions in dehydrated form for regenerating connective tissue
US20100150885A1 (en) 2005-06-01 2010-06-17 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
CA2656278C (en) * 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions and methods for treating rotator cuff injuries
US8753391B2 (en) 2007-02-12 2014-06-17 The Trustees Of Columbia University In The City Of New York Fully synthetic implantable multi-phased scaffold
US9161903B2 (en) * 2008-10-31 2015-10-20 Warsaw Orthopedic, Inc. Flowable composition that hardens on delivery to a target tissue site beneath the skin
GB0908174D0 (en) 2009-05-13 2009-06-24 Isis Innovation Steroid containing composition and uses thereof
WO2013033680A1 (en) * 2011-09-02 2013-03-07 Lifenet Health Bmp peptides & methods of use
JP2012126720A (ja) * 2010-11-26 2012-07-05 Chiba Univ コラーゲンの産生促進剤、プロテオグリカン産出促進剤及び軟骨細胞の遊走促進剤
WO2017011762A1 (en) 2015-07-16 2017-01-19 Mayo Foundation For Medical Education And Research Treating rotator cuff conditions

Similar Documents

Publication Publication Date Title
ZA202202410B (en) Rna particles comprising polysarcosine
MX2025012669A (es) Proteinas klotho recombinantes novedosas y composiciones y metodos que involucran a las mismas
MX2023008626A (es) Proteinas klotho recombinantes terapeuticas y composiciones y metodos que involucran a las mismas.
MX359953B (es) Ácido nucleico que comprende o que codifica un tallo-rizo de histona y una secuencia poli (a) o una señal de poliadenilación para incrementar la expresión de una proteína terapéutica codificada.
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
EA201200515A1 (ru) Полипептиды и их применение
WO2011036442A3 (en) Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders
MA40057A (fr) Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants
MX340541B (es) Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio.
WO2017011773A3 (en) Codon-optimized nucleic acids encoding antibodies
MX2016002152A (es) Metodo para aumentar la expresion de proteinas codificadas por arn.
NZ621868A (en) Growth hormone polypeptides and methods of making and using same
WO2017009843A3 (en) Compositions, articles of manufacture and methods for treating cancer
PE20130648A1 (es) Tratamiento del sindrome de sanfilippo tipo b
WO2014165607A3 (en) Aromatic-cationic peptide formulations, compositions and methods of use
RU2016152151A (ru) Препарат, содержащий фактор viii и пептиды фактора фон виллебранда
EA201892446A1 (ru) Фармацевтическая композиция
AR093365A1 (es) Formulacion para polipeptidos
AR095076A1 (es) Péptidos y composiciones para el tratamiento de daño articular
HK1211225A1 (en) Injectable depot formulation comprising optically active tolvaptan and process of producing the same
JP2017517561A5 (enExample)
WO2015108856A3 (en) Methods for enhancing the delivery of active agents
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
CO6160332A2 (es) Agente para terapia y/o mejoramiento de coagulacion intravascular diseminada
WO2018031730A3 (en) Peptide inhibitors of phosphoglycerate mutase and methods of use